ClinicalTrials.gg
Sign In
CompletedNCT03455595Updated Mar 12, 2018

CONECCT (Colorectal Neoplasia Endoscopic Classification To Chose the Endoscopic Treatment)

An observational study in Digestive System Disease, sponsored by Hôpital Edouard Herriot. Completed at 1 site in France. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2018-03-12.

Sponsored by Hôpital Edouard Herriot · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
60
Ages
18 Years to 90 Years
Sex
All
01

Study summary

Prospective study so as to evaluate CONECCT score to determine both histological tissue and therapeutic choice

02

Conditions studied

  • Digestive System Disease
03

In context

Digestive System Diseases

406 studies on the registry are indexed under Digestive System Diseases; 79 are open to participants now.

This study's enrollment of 60 is below the median of 400 across 105 observational studies indexed under Digestive System Diseases.

Browse Digestive System Diseases studies →

Lead sponsor

Hôpital Edouard Herriot is the lead sponsor of 17 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Population with colorectal polyps

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • N/A

Exclusion criteria

Exclusion Criteria:

  • N/A
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
60 participants (actual)
Patient registry
No

Interventions

  • ProcedureEndoscopic exams

    Coloscopy

06

What researchers measure

Primary outcomes

  1. Evaluation of the CONECCT endoscopic score so as to improve colon therapeutic treatment polyps

    There are recognized diagnostic criteria so as to predict the histology of colorectal lesions and thus to choose the right therapy. For the moment, these criteria are scattered in at least 5 different classifications and the CONECCT tool will allow gastroenterology interns to more easily predict the histology of the lesion and so to improve the management of them.

    Time frame: one year

07

Study locations

1 site
  • Edouard Herriot Hospital
    Lyon, Rhône Alpes 69437, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2017 to primary completion in Feb 2018, 12 months.

Of 45 non-industry observational studies under Digestive System Diseases, half reached primary completion within 46 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 114. This study's 12 months is below that.

Counting every sponsor, half of 56 studies reached it within 43 months; a quarter within 18 and three quarters within 102.

Digestive System Diseases covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 28, 2018
First posted
Mar 6, 2018
StartActual
Feb 1, 2017
Primary completionActual
Feb 1, 2018
CompletionActual
Feb 1, 2018
Last update
Mar 12, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 12, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03455595
Lead sponsor
Hôpital Edouard Herriot
Responsible party
Jean Christophe Saurin (Professor, Hôpital Edouard Herriot) — Principal investigator
First posted
Mar 6, 2018
Start date
Feb 1, 2017
Primary completion
Feb 1, 2018
Completion
Feb 1, 2018
Last update
Mar 12, 2018

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Digestive System Diseases →

Other studies from this sponsor

Hôpital Edouard Herriot

Start the discussion